Aqua, Centella Asiatica Leaf Water (13, 1%), Butylene Glycol, Glycerin, Dipropylene Glycol, Niacinamide (1, 000ppm), Hydroxyethyl Urea, Sodium Hyaluronate, Allantoin, Panthenol, Glutathione (1, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Adenosine, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Xanthan Gum, Propanediol, Hydroxyacetophenone, 1, 2-Hexanediol, Ethylhexylglycerin, Dipotassium Glycyrrhizate, Citric Acid, Sodium Citrate Ingredients may change
Both compounds are typically administered subcutaneously in research protocols
Pharmacokinetic Profile Route of Administration Subcutaneous Route of Administration : Subcutaneous Injection Formulation & Handling Supplied as a lyophilized powder or aqueous solution
Hevia D, Araos P, Prado C, Fuentes Luppichini E, Rojas M, Alzamora R, Cifuentes-Araneda F, Gonzalez AA, Amador CA, Pacheco R, Michea L
5.3 Ferroptosis in retinal ischemiareperfusion injury RIRI can lead to permanent vision loss
